Skip to main content
. 2022 Dec 20;12:115. doi: 10.1186/s13613-022-01087-5

Table 2.

Care trajectory in patients with necrotizing soft tissue infections (n = 170) according to immunosuppression and abdomino-perineal location status

N Total Other locations Abdomino-perineal NSTIs P-value No immunosuppression Immunosuppression P-value
N = 170 N = 137 N = 33 N = 127 N = 43
Hospital trajectory data
 Length of ICU stay (days) 170 8 [3–17] 9 [4–17] 5 [2–19] 0.207 8 [4–17] 9 [2–15] 0.500
 Length of hospital stay (days) 170 37 [14–71] 36 [14–69] 39 [16–71] 0.762 39 [16–71] 23 [9–63] 0.070
 Delay admission surgery (days) 168 1 [0 – 2] 1 [0 – 2] 1 [0 – 1] 0.495 1 [0–2] 1 [1–5] 0.004
 Annual NSTI procedural volume 170 0.601 0.638
   < 3/year 38 (22.3) 29 (21.2) 9 (27.3) 30 (23.6) 8 (18.6)
   ≥ 3/year 132 (77.6) 108 (78.8) 24 (72.7) 97 (76.4) 35 (81.4)
 Inter-hospital transfer 168 0.934 0.484
  No 80 (47.6%) 65 (48.1) 15 (45.5) 62 (49.6) 18 (41.9)
  Yes 88 (52.4%) 70 (51.9) 18 (54.5) 63 (50.4) 25 (58.1)
 Type of structure after ICU 168 0.045 0.034
  Medical ward 85 (50.6) 74 (54.8) 11 (33.3) 58 (46.0) 27 (64.3)
  Rehabilitation 10 (6.0) 9 (6.7) 1 (3.0) 10 (7.9) 0
  Plastic surgery 16 (9.5) 13 (9.6) 3 (9.1) 15 (11.9) 1 (2.4)
  Other surgical ward 57 (33.9) 39 (28.9) 18 (54.5) 43 (34.1) 14 (33.3)
Management during hospital course
 Mechanical ventilation 166 86 (51.8) 69 (51.5) 17 (53.1) 0.999 63 (50.8) 23 (54.8) 0.791
 Vasopressor support 167 129 (77.2) 105 (77.8) 24 (75.0) 0.918 97 (77.6) 32 (76.2) 0.999
 Renal replacement therapy 166 46 (27.7) 38 (28.4) 8 (25.0) 0.872 30 (24.2) 16 (38.1) 0.123
 Organ failure 167 134 (80.2) 110 (81.5) 24 (75.0) 0.561 101 (80.0) 34 (81.0) 0.999
 Skin grafting 167 54 (32.3) 46 (34.1) 8 (25.0) 0.437 46 (36.8) 8 (19.0) 0.053
 Skin grafting-first surgery (days) 36 28 [13 – 39] 28 [13 – 39] 29 [18 – 43] 0.999 25 [13 – 38] 34 [31 – 40] 0.348
 Amputation 166 26 (15.7) 24 (17.9) 2 (6.3) 0.174 22 (17.7) 4 (9.5) 0.307
 Negative pressure therapy 167 62 (37.1) 46 (34.3) 16 (48.5) 0.191 51 (40.8) 11 (26.2) 0.131
 Number of additional debridements 166 1 [0–3] 1 [0–3] 3 [1–6]  < 0.001 2 [0–3] 1 [0–2] 0.041
Outcomes
 ICU Mortality 170 37 (21.8) 30 (21.9) 7 (21.2) 0.999 21 (16.5) 16 (37.2) 0.009
 Complicated hospital coursea 169 123 (72.8) 97 (71.3) 26 (78.8) 0.518 89 (70.6) 34 (79.1) 0.382
  In-hospital mortality 170 49 (28.8) 40 (29.2) 9 (27.3) 0.996 26 (20.5) 23 (53.5)  < 0.001
  Number of debridements > 3 166 62 (37.3) 18 (13.4) 13 (40.6)  < 0.001 27 (21.8) 4 (9.5) 0.126
  Hospital stay > 6 weeks 170 156 (91.8) 62 (45.3) 16 (48.5) 0.889 61 (48.0) 17 (39.5) 0.430
 Re-hospitalization within 6 months of ICU discharge 106 66 (62.3) 49 (57.6) 17 (81.0) 0.085 56 (62.9) 10 (58.8) 0.963
 ICU readmission within 6 months 89 9 (10.1) 7 (9.3) 2 (14.3) 0.628 7 (9.6) 2 (12.5) 0.662

Qualitative variables are shown as number (percentages) and continuous variables as median [quartile 1-quartile 3]

ICU intensive care unit, NSTI necrotizing soft tissue infection

adefined by one of the following: a duration of hospital stay ≥ 6 weeks, a number of debridement performed ≥ 3, or hospital death

Bolded variables are significant at the p < 0.05 level